Patent Assignment
Reel/Frame 055516/0235
Assignment of Assignor's Interest
Recorded: 2021-03-05
Pages: 2
Assignors
THORNE, STEPHEN H.
Executed: 2020-05-28
BYRD, DANIEL J
Executed: 2020-05-21
ZHANG, MINGRUI
Executed: 2020-05-26
Assignee
KALIVIR IMMUNOTHERAPEUTICS LLC
240 ALPHA DRIVE, PITTSBURGH, PENNSYLVANIA, 15238
Covered Property
(1)
Platform Oncolytic Vector for Systemic Delivery
Application:
17/192,736 →
Publication:
US 2021/0196770
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
May 5, 2021
From: KALIVIR IMMUNOTHERAPEUTICS LLC
To: KALIVIR IMMUNOTHERAPEUTICS, INC.
Reel/Frame 056141/0995 →
Assignment of Assignor's Interest
Jan 13, 2022
From: WESTERN ONCOLYTICS LTD.
To: KALIVIR IMMUNOTHERAPEUTICS LLC
Reel/Frame 058638/0367 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 055516 Frame: 0235. Assignor(S) Hereby Confirms the Assignment .
Jan 13, 2022
From: THORNE, STEPHEN H.; BYRD, DANIEL J.; ZHANG, MINGRUI
To: WESTERN ONCOLYTICS LTD.
Reel/Frame 058720/0951 →